The Effective Statistician - in association with PSI

This podcast discusses the advantages of crossover studies in scientific research. It covers topics like randomization, order effects, and carryover effects. The challenges of conducting studies with multiple treatments are also explored, along with a case study in the allergy field. The importance of controlled environmental chambers for allergen exposure is highlighted. Overall, the podcast emphasizes the significance of understanding crossover designs in research and the potential they hold for innovative discoveries.

Understanding negotiation in the context of table production costs, reducing and restructuring tables, active listening in negotiation, investing in leadership skills, a leadership training program, modular table production concept

Jess Thompson, an expert in risk management in clinical trials, discusses the importance of continuous risk assessment, collaborative risk identification, and the role of assumptions. She also emphasizes the need for collaboration and input from team members when assessing risks, as well as contingency planning and risk reporting for successful risk management.

Katharina Schueller, a statistics professional, discusses the importance of ethical discussions among statisticians and highlights the significance of transparent communication. They explore the ethical concerns in data algorithms and the responsibilities of statisticians in putting patients first in medical statistics. The conversation also touches on the ethical implications of artificial intelligence and machine learning methods. Katharina encourages listeners to reflect on ethical aspects in their daily statistical practice and embrace the responsibilities of statisticians.

Explore strategies for managing tasks, prioritizing work, and communicating challenges in an under-resourced work environment. Learn the importance of documentation, project estimations, and maintaining a strong professional network. Discover opportunities to improve statistical skills and bring value as a statistician.

Thomas Nietmann, an expert in transitioning from SAS to R in healthcare and pharmaceutical industry, discusses how to make the transition smoother. Topics include mathematical concepts, tools to aid the transition, and a tailored course for professionals in the field.

Thomas Nietmann, an expert in transitioning from SAS to R, provides essential tips for a smooth process. Topics discussed include installing R and R Studio, data exploration techniques, data manipulation packages, macros vs. functions, and the use of unit testing. Transitioning from SAS to R can be intimidating, but with the valuable advice in this episode, the process can become smooth and painless.

The hosts discuss transitioning from SAS to R, highlighting the growth and adoption of R in big pharma. They cover exploratory data analysis in R, differences in data manipulation between SAS and R, and introduce the Merrill R package for clinical trial data manipulation.

Understand the importance of the 15% threshold in the HTA system in Germany and its impact on drug reimbursement. Learn about Health Technology Assessment and its role in assessing drug efficacy. Discover how patient-reported outcomes are used to determine noticeable changes in drug benefit. Find out why statisticians should be involved early in study design to meet the 15% threshold. Gain insights on the significance of design and collaboration in statistics.

Experienced statisticians discuss building trust in teams, having a clear vision statement, understanding higher-level decision-making in the pharmaceutical industry, and the importance of collaboration, communication, and exposure for young statisticians.